Ventas (VTR) Stock Overview
An S&P 500 company enabling exceptional environments that benefit a large and growing aging population. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 3/6 |
VTR Community Fair Values
See what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ventas, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$86.96 |
| 52 Week High | US$101.60 |
| 52 Week Low | US$66.38 |
| Beta | 0.73 |
| 1 Month Change | -4.08% |
| 3 Month Change | -3.75% |
| 1 Year Change | 26.93% |
| 3 Year Change | 106.65% |
| 5 Year Change | 54.68% |
| Change since IPO | 2,864.55% |
Recent News & Updates
VTR: Index Additions And Earnings Outlook Will Support Steady 2026 Position
Analysts have lifted their implied fair value estimate for Ventas from about $96.80 to roughly $99.05, reflecting updated assumptions that combine slightly stronger revenue growth expectations with a lower profit margin outlook and a higher future P/E multiple. What’s in the News for Ventas Ventas revised its full year 2026 attributable net income per share guidance to a range of $0.58 to $0.63, with a midpoint of $0.61.Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT
Summary Ventas is positioned as both a dividend and growth REIT, benefiting from macro tailwinds in senior housing demand. VTR’s investment-grade balance sheet, geographic diversity, and expanding portfolio underpin its resilience and modest growth outlook. Despite a rich 23x forward earnings multiple, upside forecasts are only 7%–10%, warranting a more neutral valuation stance. Dividend coverage is strong at 1.7x AFFO/share, with a 57% payout ratio and a focus on growth and safety over yield. Read the full article on Seeking AlphaRecent updates
Shareholder Returns
| VTR | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | -4.3% | -3.4% | 0.09% |
| 1Y | 26.9% | 26.1% | 19.0% |
Return vs Industry: VTR underperformed the US Health Care REITs industry which returned 30.1% over the past year.
Return vs Market: VTR exceeded the US Market which returned 20.9% over the past year.
Price Volatility
| VTR volatility | |
|---|---|
| VTR Average Weekly Movement | 4.4% |
| Health Care REITs Industry Average Movement | 4.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VTR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: VTR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 542 | Deb Cafaro | www.ventasreit.com |
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments.
Ventas, Inc. Fundamentals Summary
| VTR fundamental statistics | |
|---|---|
| Market cap | US$47.48b |
| Earnings (TTM) | US$262.73m |
| Revenue (TTM) | US$6.42b |
Is VTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTR income statement (TTM) | |
|---|---|
| Revenue | US$6.42b |
| Cost of Revenue | US$3.85b |
| Gross Profit | US$2.57b |
| Other Expenses | US$2.30b |
| Earnings | US$262.73m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 39.97% |
| Net Profit Margin | 4.09% |
| Debt/Equity Ratio | 83.4% |
How did VTR perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/11 04:48 |
| End of Day Share Price | 2026/08/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ventas, Inc. is covered by 43 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Amanda Sweitzer | Baird |
| David Rodgers | Baird |